Cargando…
ROR2 Is Epigenetically Regulated in Endometrial Cancer
SIMPLE SUMMARY: Endometrial cancer is one of the fastest rising cancers in women. The Wnt signalling receptor ROR2 has been shown to play distinct roles in regards to tumorigenesis in different tumour types. The aim of this study was to investigate the role of ROR2 in endometrial cancer and to deter...
Autores principales: | Liu, Dongli, Enriquez, Luis, Ford, Caroline E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864349/ https://www.ncbi.nlm.nih.gov/pubmed/33494187 http://dx.doi.org/10.3390/cancers13030383 |
Ejemplares similares
-
ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
por: Liu, Dongli, et al.
Publicado: (2020) -
ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021) -
Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
por: Liu, Dongli, et al.
Publicado: (2022) -
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells
por: Liu, Dongli, et al.
Publicado: (2022) -
Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1
por: John, Miya, et al.
Publicado: (2022)